Prelude Therapeutics
PRLD
PRLD
51 hedge funds and large institutions have $2.47B invested in Prelude Therapeutics in 2020 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.82% more ownership
Funds ownership: 78.48% → 79.29% (+0.82%)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
Holders
51
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$76.1M | |
| 2 | +$44M | |
| 3 | +$41.1M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$13.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$10.2M |
Top Sellers
| 1 | -$16.7M | |
| 2 | -$15.1M | |
| 3 | -$8.15M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$5.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.69M |